Dr. Severin Schwan and the AVR

The traditional meeting between Roche CEO Dr Severin Schwan and the AVR, together with Ms Cris Wilbur, Head of Group P&C, Mr Jürg Erismann, Basel/Kaiseraugst Site Head, and Mr Bruno Wissen, Head of P&C Basel/Kaiseraugst, normally takes place face-to-face in one of the large conference rooms in Building 71. Given these very different times, however, the meeting took place virtually via Zoom instead. After a brief exchange of greetings, things immediately got underway.

The Federal government tightens coronavirus measures

The Federal government tightens coronavirus measures

2020 site representative elections: the new Committee has been chosen

The results of the AVR site representative elections for Basel, Kaiseraugst, Reinach and Schlieren have been announced. The same goes for the retiree representative. This year, there is also a site representative for Diabetes Care for the very first time.

Summary of the 50+ working group and D&I generations network

Our survey on working and support preferences was conducted at the end of 2019. 620 employees at the Basel/Kaiseraugst site took part, and some of them made detailed comments that gave us important feedback. Many thanks once again!

Anniversary AGM 2020 without attendees

Due to the coronavirus pandemic, the 70th Annual General Meeting of the AVR took place on a very small scale. The Presidium and Associate Members were re-elected.

Smarten up your home with Vitra furniture

AVR members can now furnish their home office with Vitra designer furniture at preferential prices.

The AVR in coronavirus times

Even during the pandemic, the AVR is committed to the wellbeing of Roche employees.

The AVR in dialogue with the Roche CEO

At their traditional annual meeting, Roche CEO Dr Severin Schwan informed the AVR of the business results for 2019. The AVR was also able to ask questions on subjects such as reorganisations, pricing policy and the coronavirus.

Offsite-Meeting 2019

The AVR adopts agile working methods too. At its offsite meeting at the beginning of June it conducted sprint processes to seek ways of safeguarding the future of the Roche sites in Switzerland, and of protecting jobs. It also discussed the latest figures from HR – and the social side was not forgotten, either.

Introduction site representatives

Four new AVR Board members began work at the end of 2018. In the interview below, Vice President of the AVR Gernot Scharf explains how the newcomers are inducted into their Jobs.